Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review
Abstract Background Non‐melanoma skin cancers (NMSCs) are common and consume many healthcare resources. A health utility is a single preference‐based value for assessing health‐related quality of life, which can be used in economic evaluations. There are scarce data on health utilities for NMSCs. Ob...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Skin Health and Disease |
Online Access: | https://doi.org/10.1002/ski2.51 |
id |
doaj-4e9044f2436e4b45a3e6970f6e3c91ea |
---|---|
record_format |
Article |
spelling |
doaj-4e9044f2436e4b45a3e6970f6e3c91ea2021-09-01T10:51:50ZengWileySkin Health and Disease2690-442X2021-09-0113n/an/a10.1002/ski2.51Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic reviewC. So0A. E. Cust1L. G. Gordon2R. L. Morton3K. Canfell4P. Ngo5M. Dieng6K. McLoughlin7C. Watts8Sydney School of Public Health Faculty of Medicine and Health, The University of Sydney Sydney AustraliaThe Daffodil Centre The University of Sydney, a joint venture with Cancer Council NSW Sydney AustraliaPopulation Health Department QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital Brisbane AustraliaFaculty of Medicine and Health NHMRC Clinical Trials Centre, The University of Sydney Sydney AustraliaThe Daffodil Centre The University of Sydney, a joint venture with Cancer Council NSW Sydney AustraliaThe Daffodil Centre The University of Sydney, a joint venture with Cancer Council NSW Sydney AustraliaFaculty of Medicine and Health NHMRC Clinical Trials Centre, The University of Sydney Sydney AustraliaThe Daffodil Centre The University of Sydney, a joint venture with Cancer Council NSW Sydney AustraliaThe Daffodil Centre The University of Sydney, a joint venture with Cancer Council NSW Sydney AustraliaAbstract Background Non‐melanoma skin cancers (NMSCs) are common and consume many healthcare resources. A health utility is a single preference‐based value for assessing health‐related quality of life, which can be used in economic evaluations. There are scarce data on health utilities for NMSCs. Objectives Using a systematic review approach, we synthesized the current data on NMSC‐related health utilities. Methods A systematic review of studies of NMSC‐related health utilities was conducted in Medline, Embase, and Cochrane databases. Data were extracted based on the protocol and a quality assessment was performed for each study. Results The protocol resulted in 16 studies, involving 121 621 participants. Mean utility values across the studies ranged from 0.56 to 1 for undifferentiated NMSC, 0.84 to 1 for actinic keratosis, 0.45 to 1 for squamous cell carcinoma, and 0.67 to 1 for basal cell carcinoma. There was considerable variability in utilities by type of cancer, stage of diagnosis, time to treatment, treatment modality, and quality of life instrument or method. Utility values were predominantly based on the EuroQol 5‐dimension instrument and ranged from 0.45 to 0.96, while other measurement methods produced values ranging from 0.67 to 1. Lower utility values were observed for advanced cancers and for the time period during and immediately after treatment, after which values gradually returned to pre‐treatment levels. Conclusions Most utility values clustered around relatively high values of 0.8 to 1, suggesting small decrements in quality of life associated with most NMSCs and their precursors. Variability in utilities indicates that careful characterization is required for measures to be used in economic evaluations.https://doi.org/10.1002/ski2.51 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
C. So A. E. Cust L. G. Gordon R. L. Morton K. Canfell P. Ngo M. Dieng K. McLoughlin C. Watts |
spellingShingle |
C. So A. E. Cust L. G. Gordon R. L. Morton K. Canfell P. Ngo M. Dieng K. McLoughlin C. Watts Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review Skin Health and Disease |
author_facet |
C. So A. E. Cust L. G. Gordon R. L. Morton K. Canfell P. Ngo M. Dieng K. McLoughlin C. Watts |
author_sort |
C. So |
title |
Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review |
title_short |
Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review |
title_full |
Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review |
title_fullStr |
Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review |
title_full_unstemmed |
Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review |
title_sort |
health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: a systematic review |
publisher |
Wiley |
series |
Skin Health and Disease |
issn |
2690-442X |
publishDate |
2021-09-01 |
description |
Abstract Background Non‐melanoma skin cancers (NMSCs) are common and consume many healthcare resources. A health utility is a single preference‐based value for assessing health‐related quality of life, which can be used in economic evaluations. There are scarce data on health utilities for NMSCs. Objectives Using a systematic review approach, we synthesized the current data on NMSC‐related health utilities. Methods A systematic review of studies of NMSC‐related health utilities was conducted in Medline, Embase, and Cochrane databases. Data were extracted based on the protocol and a quality assessment was performed for each study. Results The protocol resulted in 16 studies, involving 121 621 participants. Mean utility values across the studies ranged from 0.56 to 1 for undifferentiated NMSC, 0.84 to 1 for actinic keratosis, 0.45 to 1 for squamous cell carcinoma, and 0.67 to 1 for basal cell carcinoma. There was considerable variability in utilities by type of cancer, stage of diagnosis, time to treatment, treatment modality, and quality of life instrument or method. Utility values were predominantly based on the EuroQol 5‐dimension instrument and ranged from 0.45 to 0.96, while other measurement methods produced values ranging from 0.67 to 1. Lower utility values were observed for advanced cancers and for the time period during and immediately after treatment, after which values gradually returned to pre‐treatment levels. Conclusions Most utility values clustered around relatively high values of 0.8 to 1, suggesting small decrements in quality of life associated with most NMSCs and their precursors. Variability in utilities indicates that careful characterization is required for measures to be used in economic evaluations. |
url |
https://doi.org/10.1002/ski2.51 |
work_keys_str_mv |
AT cso healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview AT aecust healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview AT lggordon healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview AT rlmorton healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview AT kcanfell healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview AT pngo healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview AT mdieng healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview AT kmcloughlin healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview AT cwatts healthutilitiesfornonmelanomaskincancersandprecancerouslesionsasystematicreview |
_version_ |
1721182755994206208 |